1. Home
  2. LIQT vs JSPR Comparison

LIQT vs JSPR Comparison

Compare LIQT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LiqTech International Inc.

LIQT

LiqTech International Inc.

HOLD

Current Price

$1.89

Market Cap

20.4M

Sector

Technology

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

HOLD

Current Price

$0.92

Market Cap

24.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIQT
JSPR
Founded
2004
2018
Country
Denmark
United States
Employees
N/A
22
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
24.4M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
LIQT
JSPR
Price
$1.89
$0.92
Analyst Decision
Strong Buy
Buy
Analyst Count
1
11
Target Price
$4.30
$15.50
AVG Volume (30 Days)
13.0K
218.6K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$42.12
N/A
Revenue Next Year
$63.48
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.22
$0.62
52 Week High
$3.35
$7.19

Technical Indicators

Market Signals
Indicator
LIQT
JSPR
Relative Strength Index (RSI) 39.05 49.02
Support Level $1.78 $0.81
Resistance Level $2.06 $1.03
Average True Range (ATR) 0.20 0.08
MACD -0.06 0.00
Stochastic Oscillator 6.48 54.61

Price Performance

Historical Comparison
LIQT
JSPR

About LIQT LiqTech International Inc.

LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is renowned in three business areas: ceramic membranes and membrane incorporated liquid filtration systems, ceramic diesel particulate filters (DPFs) to control soot exhaust particles and black carbon emission from diesel engines, and plastic components for usage across various industries. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, Hybrid Technology Membranes and others. The Company operates through three reportable segments: Systems and Aftermarket, Filters and Membranes, and Components.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: